The Effectiveness of a Care Bundle to Prevent Postpartum Hemorrhage After Cesarean Delivery
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: A care bundle.
- Who it may be relevant to
- Registry conditions: Cesarean Delivery. Basic parameters: No limits · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A Cluster Randomized Trial on the Effectiveness of a Care Bundle to Prevent Postpartum Hemorrhage After Cesarean Delivery (Re-Team)
Overview
Delays in the detection or inconsistent use of effective interventions of postpartum hemorrhage can result in complications or death. We designed a cluster-randomized trial to assess a multi-component strategy for the detection and treatment of postpartum hemorrhage after cesarean delivery.
Interventions
- Other A care bundle
1. Risk evaluation for PPH and Reserve plan; 2. Assess blood loss using Estimated Blood Loss Form and amnion fluid collection drape; 3. Satisfy any of the following conditions: i. If the estimated blood loss reaches 500ml but is less than 1000ml, and any of the following abnormal indicators are present; ii. If the estimated blood loss reaches 1000ml, no other indicators need to be considered: 1） Lack of uterine contractions 2） Persistent bleeding 3）Shock index (heart rate/systolic blood pressure
Primary outcome measures
- Incidence of PPH [Time frame: Day 2]
Secondary outcome measures (7)
- mean total calculated blood loss [Time frame: Day 2]
- Estimated blood loss [Time frame: postpartum 24 hours]
- Incidence of postpartum transfusion [Time frame: baseline]
- Incidence of additional operations performed outside cesarean section [Time frame: baseline]
- Incidence of transfer to intensive care unit [Time frame: baseline]
- Incidence of maternal death from any cause [Time frame: Up to 42 days]
- The adherence to the treatment bundle [Time frame: intraoperation and postpartum 24 hours]
Eligibility criteria
Inclusion criteria
- Hospital level
- Public hospitals
- There are more than 100 cesarean deliveries per year
- Patient level
- Cesarean delivery
- Sign informed consent
Exclusion criteria
- Hospital level
1\. Data verification information cannot be provided
- Pregnant woman level 1. No blood routine results within 2 weeks before surgery
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT06684080 · RE-TEAM